Summary
Agilent Technologies (via its acquisition of Lasergen) partnered with BeanStock Ventures to transform a manual engineering control tool into a fully automated clinical-grade platform. BeanStock built a custom software development team, integrated across four organizations, and delivered a complex, end-to-end sequencing instrument control system—achieving full platform integration in just six months. This success accelerated productization and helped secure Agilent’s expansion in the life sciences space.
Challenge
Lasergen, acquired by Agilent Technologies in 2018, had a mature NGS platform but limited in-house resources to scale its software into a market-ready, clinical-grade system. The key challenges included:
- Lack of internal software productization expertise
- A highly complex program spanning R&D, secondary analysis, and systems integration
- Need for rapid execution to meet business and acquisition milestones
- Cross-organizational coordination across four stakeholder groups
BeanStock Ventures Fast Track Solution
🧭 Development Strategy
BeanStock led the end-to-end software strategy:
- Defined product architecture and UX
- Integrated secondary analysis workflows
- Facilitated agile ceremonies and sprint planning across four groups
- Delivered alignment on life science instrument planning across R&D, clinical, service, and system teams
🛠️ Systems Engineering and UX Design
Our Bedrock-based software framework accelerated the development of:
- A scalable instrument control system
- User and technician-facing GUIs with human factors design
- Integrated workflows for sequencing, run result tracking, and exception handling
- Debugging tools for real-time support and field testing
📄 Documentation & Compliance
Even though the platform was pre-commercial, BeanStock implemented clinical-grade design controls:
- Architecture and interface specifications
- Design history file elements and traceability structure
- Debug logging, error handling documentation, and risk controls
- Internal quality software processes tailored to scale with Agilent’s QMS
🚀 Software Execution
BeanStock deployed a custom-built 12-person team, integrated with Lasergen’s existing engineers in less than 6 weeks.
- Delivered clinical platform software in <6 months
- Coordinated with vendors across sequencing, optics, and analytics
- Managed all program sprints, demos, and technical reviews
Outcome
| Metric | Outcome |
|---|---|
| Team Integration Time | < 6 weeks |
| Clinical Software System Delivery | 6 months (end-to-end) |
| Cross-org Coordination | 4 stakeholder orgs managed seamlessly |
| Business Impact | Supported Lasergen’s acquisition by Agilent |
| Program Complexity Managed | Multi-system integration with secondary analysis, GUI, and service modules |
💬 Client Feedback
“Thank you, BeanStock Ventures, for the successful collaboration in software development and managing a highly complex program. We were impressed with the successful integration of your experts with our R&D team and the achievement of end-to-end integration in six months. Your creation of a custom team to complement ours and provide leadership in software strategy, interface design, and system planning was professional, effective, and aligned with our business needs.”
— Mimi Healy, Former CEO, Lasergen and Head of NGS Services at Agilent Technologies
🧠 Why BeanStock Ventures?
- Proven Rapid Delivery – Delivered a fully integrated, clinical-grade sequencing control platform in just 6 months for Agilent Technologies.
- Custom, Embedded Teams – Build specialized software & verification teams that integrate with your org in under 6 weeks.
- End-to-End Capability – From architecture & UX to system integration, compliance, and post-launch support.
- Domain Depth – Expertise across NGS, clinical workflows, life sciences instrumentation, and regulated software (SaMD).
- Time-to-Market Acceleration – Our Bedrock platform and agile approach consistently cut months off traditional launch timelines.
📩 Want to accelerate your clinical software launch?Let’s build together.
📧 marketing@beanstockventures.com